Interferon beta-1b for COVID-19

doi:10.1016/S0140-6736(20)31101-6

Comment

. 2020 May 30;395(10238):1670-1671.

doi: 10.1016/S0140-6736(20)31101-6. Epub 2020 May 10.

Interferon beta-1b for COVID-19

Sarah Shalhoub¹

Affiliations

PMID: 32401712
PMCID: PMC7211497
DOI: 10.1016/S0140-6736(20)31101-6

Comment

Interferon beta-1b for COVID-19

Sarah Shalhoub. Lancet. 2020.

. 2020 May 30;395(10238):1670-1671.

doi: 10.1016/S0140-6736(20)31101-6. Epub 2020 May 10.

Author

Sarah Shalhoub¹

Affiliation

¹ Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada. Electronic address: sarah.shalhoub@lhsc.on.ca.

PMID: 32401712
PMCID: PMC7211497
DOI: 10.1016/S0140-6736(20)31101-6

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Comment on

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Hung IF, et al. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10. Lancet. 2020. PMID: 32401715 Free PMC article. Clinical Trial.

Cited by

Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.
Sang ER, Tian Y, Gong Y, Miller LC, Sang Y. Sang ER, et al. Heliyon. 2020 Sep;6(9):e04818. doi: 10.1016/j.heliyon.2020.e04818. Epub 2020 Aug 31. Heliyon. 2020. PMID: 32904785 Free PMC article.
Novel coronavirus disease (COVID-19) pandemic: A recent mini review.
Rehman MFU, Fariha C, Anwar A, Shahzad N, Ahmad M, Mukhtar S, Farhan Ul Haque M. Rehman MFU, et al. Comput Struct Biotechnol J. 2021;19:612-623. doi: 10.1016/j.csbj.2020.12.033. Epub 2020 Dec 31. Comput Struct Biotechnol J. 2021. PMID: 33398233 Free PMC article. Review.
Interferon Resistance of Emerging SARS-CoV-2 Variants.
Guo K, Barrett BS, Mickens KL, Vladar EK, Morrison JH, Hasenkrug KJ, Poeschla EM, Santiago ML. Guo K, et al. bioRxiv [Preprint]. 2021 Dec 10:2021.03.20.436257. doi: 10.1101/2021.03.20.436257. bioRxiv. 2021. Update in: Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203760119. doi: 10.1073/pnas.2203760119. PMID: 33758840 Free PMC article. Updated. Preprint.
Targeting the immunology of coronavirus disease-19: synchronization creates symphony.
Ahmed S, Anirvan P. Ahmed S, et al. Rheumatol Int. 2020 Aug;40(8):1343-1345. doi: 10.1007/s00296-020-04624-2. Epub 2020 Jun 12. Rheumatol Int. 2020. PMID: 32533292 Free PMC article. No abstract available.
Expert Opinions on the Most Promising Treatments and Vaccine Candidates for COVID-19: Global Cross-sectional Survey of Virus Researchers in the Early Months of the Pandemic.
Cabral BP, Braga L, Mota F. Cabral BP, et al. JMIR Public Health Surveill. 2021 Feb 26;7(2):e22483. doi: 10.2196/22483. JMIR Public Health Surveill. 2021. PMID: 33635275 Free PMC article.

See all "Cited by" articles

References

1. WHO . World Health Organization; Geneva: April 29, 2020. Coronavirus disease 2019 (COVID-19). Situation report 100.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
1. Shi X, Lu Y, Li R. Evaluation of antiviral therapies for coronavirus disease 2019 (COVID-19) pneumonia in Shanghai, China. J Med Virol. 2020 doi: 10.1002/jmv.25893. published online April 16. - DOI - PMC - PubMed
1. Chu CM, Cheng VCC, Hung IF. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252–256. - PMC - PubMed
1. Zhao Z, Zhang F, Xu M. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–720. - PubMed
1. Arabi YM, Shalhoub S, Mandourah Y. Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study. Clin Infect Dis. 2020;70:1837–1844. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] WHO . World Health Organization; Geneva: April 29, 2020. Coronavirus disease 2019 (COVID-19). Situation report 100.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...

[2] WHO . World Health Organization; Geneva: April 29, 2020. Coronavirus disease 2019 (COVID-19). Situation report 100.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...

[3] Shi X, Lu Y, Li R. Evaluation of antiviral therapies for coronavirus disease 2019 (COVID-19) pneumonia in Shanghai, China. J Med Virol. 2020 doi: 10.1002/jmv.25893. published online April 16. - DOI - PMC - PubMed

[4] Shi X, Lu Y, Li R. Evaluation of antiviral therapies for coronavirus disease 2019 (COVID-19) pneumonia in Shanghai, China. J Med Virol. 2020 doi: 10.1002/jmv.25893. published online April 16. - DOI - PMC - PubMed

[5] Chu CM, Cheng VCC, Hung IF. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252–256. - PMC - PubMed

[6] Chu CM, Cheng VCC, Hung IF. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252–256. - PMC - PubMed

[7] Zhao Z, Zhang F, Xu M. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–720. - PubMed

[8] Zhao Z, Zhang F, Xu M. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–720. - PubMed

[9] Arabi YM, Shalhoub S, Mandourah Y. Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study. Clin Infect Dis. 2020;70:1837–1844. - PMC - PubMed

[10] Arabi YM, Shalhoub S, Mandourah Y. Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study. Clin Infect Dis. 2020;70:1837–1844. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Interferon beta-1b for COVID-19

Affiliation

Interferon beta-1b for COVID-19

Author

Affiliation

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical